Brazil Is Running Out of Ingredients for Astra, Sinovac Shots
May 13 2021, 2:58 AM
May 12 2021, 11:56 PM
May 13 2021, 2:58 AM
(Bloomberg) Ingredients used to produce AstraZeneca Plcâs Covid-19 shot in Brazil could run out by the end of the week, exacerbating an already precarious mass vaccine campaign that has struggled to ramp up local production.The Rio de Janeiro-based research institute Fiocruz, which partnered with Astra to produce the shot locally, has enough of the so called IFA the active ingredient to make the vaccines to sustain output un.
(Bloomberg) Ingredients used to produce AstraZeneca Plcâs Covid-19 shot in Brazil could run out by the end of the week, exacerbating an already precarious mass vaccine campaign that has struggled to ramp up local production.
Brazil’s COVID-19 death toll is now almost 337,000, next only to the U.S. To date, Brazil has recorded more than 13 million cases of COVID-19. Some 66,570 people died with COVID-19 in March, more than double the previous monthly record.
Brazil is brewing new variants every week
“It’s the largest human tragedy in Brazilian history,” he said. “We may get to 500,000 deaths by July 1, that’s the latest estimate.”
Nicolelis quickly corrected himself, citing the estimates released by the
University of Washington. “If the rate of transmission goes up by about 10 percent, we could get to 600,000 deaths,” he said.
“It’s a nuclear reactor that has set off a chain reaction and is out of control. It’s a biological Fukushima,” he said, referring to the accident at the Fukushima Daiichi nuclear power plant in Japan that was sparked by a tsunami in 2011. (Related: Brazil relives the worst of the pandemic as coronavirus cases and deaths surge anew.)
by Bhaswati Guha Majumder - Apr 12, 2021 11:27 AM
Representative image (Unsplash)
Snapshot
India, which is classified as a lower-middle-income country by the World Bank, has successfully administered around 104 million vaccine doses as of the day.
Five per cent of the world population has been fully vaccinated against the Covid-19. But as per a recent report, most of the vaccines are going to the wealthiest nations.
An analysis of data collected by the Bloomberg Vaccine Tracker has revealed that as of now, countries making up the least-wealthy 11 per cent have gotten around 1.6 per cent of the vaccines administered.
While the United States, United Kingdom and UAE and Israel have been providing as many vaccine doses as possible to their countrymen, the worldâs least wealthy continent, Africa, remains as the least vaccinated region.
RIO DE JANEIRO
Brazilian President Jair Bolsonaro insisted Wednesday that there will be “no national lockdown,” ignoring growing calls from health experts a day after the nation saw its highest number of COVID-19 deaths in 24 hours since the pandemic began.
Brazil’s Health Ministry registered 4,195 deaths Tuesday, becoming the third country to exceed the 4,000 daily mark as Bolsonaro’s political opponents demanded stricter measures to slow down the spread of the coronavirus. Brazil has now recorded nearly 341,000 COVID-19 deaths, second only to the death toll in the U.S., according to Johns Hopkins University.
But Bolsonaro, who has dismissed the disease as “a little flu,” has consistently resisted pressure to impose health restrictions on his country.
3 Min Read
RIO DE JANEIRO (Reuters) - Brazil could begin full production of AstraZeneca Plc’s COVID-19 vaccine by July if regulators allow, an official at biomedical center Fiocruz said, moving up by 100 days the timeline to produce shots without imported ingredients.
FILE PHOTO: A healthcare worker holds a vial of the AstraZeneca/Oxford coronavirus disease (COVID-19) vaccine at a public hospital in Rio de Janeiro, Brazil, January 27, 2021. REUTERS/Pilar Olivares
Fiocruz Vice President Marco Krieger told Reuters that, if health regulator Anvisa waives some controls, the biomedical institute could move up the Sept. 30 target date for 100% local production of the shot by AstraZeneca and Oxford University.